Oxford-AstraZeneca vaccine

New Delhi: A rare neurological disorder called Guillain-Barre syndrome have been found in 11 individuals who had received the AstraZeneca-Oxford COVID-19 vaccine. According to the two…

Australia on Friday reported the first death linked to blood clots, post administration of Oxford-AstraZeneca vaccine. The 48-year-old woman was injected with the vaccine on April 8,…

London: There is more encouraging news on the COVID vaccine front. The UK is expected to authorize the Oxford-AstraZeneca vaccine by December 28 or 29 while the US Food and Drug…

London: The Oxford-AstraZeneca coronavirus vaccine is showing a strong immune response in adults whose age are in the 60s and 70s. The Lancet phase 2 findings, based on 560 healthy adult…